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CHAPTER ONE 
INTRODUCTION 
Sepsis and multiple organ failure are the leading complications in patients who 
sustain serious burn injuries. 75% of all deaths are related to sepsis or infectious 
complications arising from the injury
 1
. Following insult, there is an immediate systemic 
inflammatory response that spreads throughout the body and affects secondary organs
 2
. 
In addition to the skin, there is reported inflammation in the lungs, liver, and intestines 
after burn injury
 3
. This inflammation, coupled with a suppressed adaptive immune 
response, increases the risk of organ failure and septic infections. Bacterial infections 
may arise externally from the environment or internally from opportunistic pathogens 
that are members of the commensal microbial flora.  
The gastrointestinal tract contains over 100 trillion microbes, termed the 
microbiota, that live symbiotically and provide numerous benefits for the host such as 
metabolism and de novo synthesis of nutrients, protection against pathogenic microbes, 
and immune development and function
 4
. Under healthy homeostatic conditions, the gut 
functions as an epithelial barrier that segregates the commensal bacteria from host tissue 
and prevents inadvertent activation of an immune response. However, after trauma, this 
barrier may break down allowing for translocation of bacteria or endotoxin from the gut 
to extraintestinal sites, which can then lead to sepsis and organ failure
 5-7
. The precise 
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mechanisms of post burn induced gut barrier breakdown and its role in the pathology of 
infections and organ failure remain to be elucidated.   
Since the immune system’s principal role is the recognition of self from non-self, 
the innate and adaptive immune system function in parallel to establish tolerance to the 
commensal microbes in the gut. This tolerance is maintained by certain protective 
bacterial species and broken by imbalances in bacterial communities and overgrowth of 
pathogenic microbes
 8,9
. The innate immune system directly regulates the intestinal 
microbiota and protects against pathogenic infections through the production of 
antimicrobial peptides (AMPs). AMPs are small endogenously expressed proteins 
produced largely by epithelial and immune cells to kill microbes. A few studies have 
suggested a protective function of AMPs following burn injury but none have 
investigated the role these proteins play in regulating the intestinal microbiota and gut 
barrier following burn injury
 7,10
. Furthermore, the bacterial diversity of the gut and its 
potential role in inducing intestinal inflammation and permeability following burn injury 
remain largely unexplored.  
Understanding the mechanisms exploited by intestinal bacteria to cause post burn 
pathogenic complications may yield novel therapeutics for patients struggling with these 
conditions. Probiotic therapy, or introduction of protective gut bacteria, is revealing 
promising results in restoring the microbiome, reducing gut leakiness, and alleviating 
intestinal inflammation in colitis and other conditions, but has not yet been studied nor 
implemented as a post burn treatment
 8,11
. The studies performed herein identify burn-
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induced alterations of the intestinal microbiota and increases of gut permeability and 
inflammation.  
Hypothesis 
Burn injury decreases the expression of antimicrobial peptides, which leads to 
alterations in the intestinal microbiota and contributes to an increase of intestinal 
permeability and inflammation.  
Specific Aim 1 
Determine whether burn injury decreases expression of AMPs and alters the 
intestinal microbiome of the small and large intestine. 
Rationale 
The antimicrobial peptides α-defensins and C-type lectins have been implicated in 
the establishment and regulation of the intestinal microbiota. Recent studies have shown 
that a reduction in α-defensins promote shifts in microbial communities and the 
overgrowth of pathogenic bacteria, which can lead to intestinal inflammation in Crohn’s 
disease
 12-14
.  C-type lectins are another class of antimicrobials which protect against 
intestinal inflammation and colitis by segregating the commensal bacteria from the 
intestinal epithelium. However, it is not known how burn injury changes the expression 
of these two antimicrobials in the small intestine. Therefore we will determine whether 
burn injury leads to a change in the expression of α-defensins and C-type lectins in the 
gut.  
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Next, we will determine whether changes in these classes of antimicrobials 
accompany shifts in the relative diversity of the intestinal microbiota. Previous research 
from our laboratory and others have shown increases in total and Gram-negative bacteria 
in the intestines and mesenteric lymph nodes (MLN) by culture following burn injury
 15
. 
This suggests that Gram-negative bacteria are able to outcompete the rest of the 
commensal bacteria and lead to potential phylogenetic shifts in the microbial flora. 
However, it is not known how the diversity of the microbiome is altered following burn 
injury. The healthy microbiota has been shown to possess immunomodulatory and 
immunostimulatory functions and expansion of opportunistic pathogenic bacteria may 
skew the immune response to promote increases of intestinal inflammation and 
permeability as is seen in chronic inflammatory diseases such as inflammatory bowel 
disease (IBD)
 16
. Thus, experiments will further determine how burn injury alters the 
diversity of the intestinal microbiota, with a focus on abundant bacterial phyla and 
specific groups that have anti-inflammatory or proinflammatory potential.  
Specific Aim 2 
 Determine whether burn injury increases gut permeability and inflammation. 
Rationale 
Previous data has identified the gut as a cytokine-generating organ in response to 
burn injury but no studies have established a link between alterations in the microbial 
flora inducing intestinal inflammation following burn
 17
. Therefore experiments will 
determine which specific cytokines and chemokines change in the intestines and when 
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these changes occur following injury. In addition, we will determine whether these 
changes in inflammatory mediators accompany changes in specific groups of bacteria. 
Furthermore, the intestine is physiologically impermeable to the luminal bacteria, 
however, a breakdown in the epithelial barrier may allow for bacterial translocation to the 
MLN. Published data from our laboratory show increases of culturable bacteria in the 
MLN following burn injury, but these bacteria were not identified nor measured in the 
intestines
 7
. Thus, we will first determine whether burn increases gut leakiness and 
bacterial translocation and whether these bacteria that are present in the MLN are also 
increased in the small or large intestines. Hence, experiments in this aim will determine 
whether intestinal inflammation and permeability may be due to increases in pathogenic 
or pro-inflammatory groups of bacteria.  
 
Specific Aim 3 
 Determine whether probiotic treatment of Lactobacillus gg restores the gut barrier 
following burn injury. 
Rationale 
Probiotic treatment has shown to reduce intestinal inflammation in various mouse 
models of colitis and may show some benefit in patient cohorts of inflammatory bowel 
disease. Lactobacillus rhamnosus GG is bacterial strain with anti-inflammatory 
properties that attaches to the intestinal epithelial cells and secretes proteins, p40 and p75, 
which reduce inflammatory cytokines, and increase expression of tight junction  
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proteins
 11,18,19
. Therefore experiments in this aim will determine whether in vivo 
treatment of Lactobacillus gg probiotic reduces intestinal inflammation and leakiness 
following burn injury.  
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CHAPTER TWO 
REVIEW OF LITERATURE 
Burn Injury 
Burn injury accounts for approximately half a million cases requiring medical 
treatment and 4,000 deaths reported annually each year
 20
. Of these deaths, sepsis and 
multiple organ dysfunction syndrome (MODS) remain the leading causes of mortality in 
burn related trauma
 5,21
. Following burn injury, patients suffer a global immune 
dysregulation characterized by a heightened innate proinflammatory response and 
subsequently followed by a compromised adaptive immune response
 5
. This innate 
response, termed systemic inflammatory response syndrome (SIRS), is marked by an 
increase of cytokines, chemokines, and acute phase proteins. The host response to injury 
induces a “cytokine” storm of TNF, IL-1, -6, and -8 as well as elevated levels of acute 
phase proteins such as serum amyloid A, and C-reactive protein
 22,23
. Ensuing, this initial 
response is a counter anti-inflammatory response (CARS) marked by decreased T cell 
proliferation, Th1 and Th17 cell responses, and antigen presentation
 2,3,6,7,23
. It is 
hypothesized that this disruption in immune homeostasis from injury predisposes 
susceptible individuals to opportunistic infections
 2
. These infections may be derived 
externally from the environment or internally from the indigenous commensal bacteria.  
Burn Injury and Gut Barrier Dysfunction 
8 
 
 
 
Since the gut is a reservoir of an enormous amount of bacteria in the body, it has 
the potential to become a major clinical problem following burn related trauma increasing 
the susceptibility of patients to developing septic infections
 5,6
. In the context of the gut, 
burn injury may lead to a breakdown in the epithelial barrier characterized by increased 
apoptotic cell death and enhanced production of proinflammatory mediators allowing for 
the translocation of viable bacteria or endotoxin to extraintestinal sites
 17,24-27
. This barrier 
dysfunction may allow gut derived factors to travel into the lymphatic circulation to the 
mesenteric lymph nodes (MLN), liver, and lungs to produce systemic tissue damage and 
increase the risk for septic complications
 24
. Studies have shown that viable bacteria may 
be cultured from the MLN days after the injury suggesting prolonged alterations in 
intestinal permeability after burn
 15
. These observations led to the gut origin hypothesis of 
multiple organ dysfunction syndrome, which describe the gut or gut-derived factors as 
possible sources of sepsis or MODS
 5
. 
Ischemia, reperfusion injury, and gut bacteria are all burn induced factors which 
can potentiate this barrier breakdown leading to increases of inflammation and 
permeability. Immediately following injury, there is a severe mesenteric vasoconstriction 
as blood is diverted from the intestines to the site of injury to aid in wound healing
 5
. This 
vasoconstriction, produces an ischemic environment for the gut, and this lack of oxygen, 
may lead to cell death and inflammation in the intestinal bed
 28
. On the other hand, the 
vigorous reperfusion and diversion of blood back to the intestines may augment this 
inflammation
 29
. Increases of inflammatory cytokines and chemokines have been reported 
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in the feces of burn patients
 30
. This inflammatory environment allows for the overgrowth 
of luminal intestinal bacteria. Although it not known how the diversity of the intestinal 
flora is altered following burn injury and the relative impact this has on the host, there are 
data suggesting the overgrowth of Gram-negative bacilli
 31,32
. Gram-negative infection 
and LPS are potent inducers of TNFα signaling and neutrophil recruitment, which can 
potentially lead to tissue damage, increased permeability in the intestines after burn, and 
septic shock
 33-35
.  
The Intestinal Epithelial Barrier 
The gut is an organ specialized for the digestion and absorption of nutrients. 
These processes are due in large part to the commensal bacteria which facilitate the 
digestion of complex plant polysaccharides and the synthesis of essential vitamins that 
humans are incapable of
 36
. In turn, our digestive tract provides a nutrient rich ecosystem 
that aids the development of complex bacterial communities. This coevolution of 
microbial mutualism accompanied the development of elaborate mechanisms to promote 
tolerance and to prevent our immune system from generating inflammatory responses 
against these bacteria
 36
. At the host microbial interface is a mucosal barrier which 
physically separates bacteria from the intestinal tissue. Specialized secretory epithelial 
cells, goblet cells, secrete mucus which contains hydrated glycoproteins, 
immunoglobulins, and antimicrobial peptides. The mucus layer of both the small and 
large intestine is composed of an outer and inner layer. Since mucin glycoproteins 
sterically hinder bacteria from attaching to the intestinal epithelial cells, bacteria are 
10 
 
 
 
usually found in the outer mucus layer and the inner layer which is relatively devoid of 
bacteria
 37
. There are some species that do however attach to the intestinal epithelial cells, 
and interaction of these bacteria with pattern recognition receptors, Toll-like receptors 
and Nod-like receptors, is necessary for homeostasis in the intestine
 38,39
. B cells in the 
lamina propria produce IgA which is transported and secreted into the intestinal lumen. 
This immunoglobulin binds antigens on commensal bacteria and prevents invasion from 
pathogenic microbes
 40
. Antimicrobial peptides are secreted from specialized epithelial 
cells, Paneth cells, located in the intestinal crypts. These proteins aid in spatial 
segregation, regulate the commensal flora, and protect against pathogenic infection.  
The intestine is also a selectively permeable organ allowing for the bidirectional 
flow of nutrients and wastes but impermeable to the translocation of bacteria from the 
lumen to the lamina propria
 41
. This seal is maintained by tight junction proteins (TJ), 
which are transmembrane proteins composed of claudin and occludin, that prevent the 
paracellular transport of molecules. Furthermore, adherens junctions and desmosomes 
further assist in maintaining this cell-to-cell connectivity in the intestine.  
Following injury or inflammation, this barrier may break down allowing for the 
invasion and translocation of commensal microbes into the epithelium. Certain members 
of the commensal flora can exploit this environment and become opportunistic pathogens 
and lead to infection and disease
 42
.  
Antimicrobial Peptides 
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The innate immune system is directly involved in maintaining the tolerogenic 
mucosal and commensal bacterial interface in the gut through physical and chemical 
regulatory networks, both of which maintain gut impermeability and prevent chronic 
inflammation by restricting contact of resident bacteria with intestinal epithelial cells. 
Antimicrobial peptides (AMPs) are proteins that are constitutively produced at mucosal 
surfaces by epithelial and lymphoid cells to regulate commensal bacteria and to protect 
against pathogenic microbial infections. These peptides are small proteins (12-50 amino 
acids) that possess an amphipathic structure and a net cationic charge. In addition to 
participating in direct bacterial killing, AMPs have other diverse functions such as 
chemotactic activity, and wound repair
 43
.  
Defensins are a major family of AMPs, and the α-defensins are the most highly 
expressed antimicrobial in the human gastrointestinal tract
 44
. These proteins are 
produced mainly by Paneth cells, specialized secretory intestinal epithelial cells, which 
are found at the base of the crypts of Lieberkühn. In humans, two Paneth cell specific α-
defensins have been identified, HD-5, and 6. Interestingly, mice express  ~19 
evolutionarily related proteins that are homologous to human α-defensins termed 
cryptdins or cryptdin-related sequence (CRS) peptides
 45
. α-defensins are constitutively 
expressed as inactive pro-peptides and proteolytically processed to the mature form by 
trypsin in humans and MMP-7 in mice, whereby they are secreted into the intestinal 
lumen. These AMPs possess a cationic charge and are electrostatically attracted to 
negatively-charged microbial membranes forming pores which lyse bacterial cells. This 
12 
 
 
 
class of AMPs has broad range microbicidal activity against both Gram-positive and 
Gram-negative bacteria as well as fungi such as: Listeria monocytogenes, Escherichia 
coli, S. typhimurium and Candida albicans
 46
.  
Another key class of antimicrobials in the intestine is the regenerating (REG) 
family of C-type lectins, Reg3α or HIP/PAP in humans and Reg3γ in mice. These 
antimicrobials possess a carbohydrate recognition domain (CRD), which facilitates the 
binding of Reg3 to peptidoglycan present on Gram-positive bacteria
 47,48
. Once bound, 
Reg3 is able to form hexameric membrane-permeabilizing oligomeric pores which 
selectively lyse only Gram-positive bacteria
 49
. Similar to the α-defensins, these peptides 
are primarily produced by the Paneth cells of the small intestine, but in contrast, their 
production is induced by Toll-like receptor stimuli from the resident microbiota and 
inflammatory stimuli.  
In the literature, both α-defensins and Reg3γ have been implicated in the 
establishment, regulation, and segregation of the healthy intestinal microbiota 
 12,44,50-53
. 
Reduction or overexpression of these proteins can alter bacterial communities and 
intestinal homeostasis allowing for an increase in inflammation
 12
. It is hypothesized that 
Paneth cell dysfunction of antimicrobial release can lead to disease development such as 
inflammatory bowel diseases (IBD), Crohn’s disease and Ulcerative Colitis (UC), which 
are chronic inflammatory conditions of the gut
 51
. Furthermore, Crohn’s disease patients 
show a reduction of α-defensins in the ileum 14. This attenuation of α-defensin expression 
is linked to aberrant inflammasome signaling in Crohn’s patients with NOD2  
13 
 
 
 
mutations
 54
. Since knockouts of α-defensin genes are embryonic lethal, mouse models 
have been developed to study the role of α-defensins in intestinal homeostasis by utilizing 
MMP-7
-/-, the protein involved in processing the mature secreted form of α-defensins, 
and transgenic mice overexpressing human HD-5
 55
. Results from these experiments 
show that α-defensins regulate the composition of the intestinal microbiota and 
reductions of these proteins have the potential to skew the microbiota toward a 
proinflammatory phenotype
 12. Similar to α-defensins, Reg3γ is also involved in 
maintaining the microbiota
 56. Hooper’s laboratory showed that the spatial segregation of 
the commensal bacteria from the intestine tissue is dependent on the expression of this 
antimicrobial. Reg3γ-/- showed an altered microbiota composition and increased bacterial 
colonization of the intestinal epithelial surface
 50
.  
The Intestinal Microbiota 
All mammalian epithelial surfaces are colonized by a diverse consortium of 
microbes collectively known as the microbiota, and their genetic composition is termed 
the microbiome. In the human body, there are approximately 100 trillion microbial cells, 
which outnumber human cells 10 to 1 and contain 100 times as many genes as our own 
genome
 57
. Establishment of this microbiota occurs immediately following birth, and it is 
the temporal and spatial colonization of these microbes, which help shape our developing 
immune system. The vast majority of these symbiotic microbes, upwards of ~1000 
different bacterial species and 100 trillion organisms, inhabit the gastrointestinal tract and 
provide numerous physiological benefits for the host including metabolism of nutrients, 
14 
 
 
 
vitamin synthesis, colonization resistance, and immune development and function
 58
. 
Abnormal development or ecological disturbances of these microbial communities play 
critical roles in determining health and disease.  
Diversity of the Healthy Gut Microbiome 
As infants, the phylogenetic diversity and functional capacity of our intestinal 
microbiota drastically increases in the first three years of life. Succession of bacterial 
communities abruptly changes with the introduction of various life events such as breast-
feeding, solid foods, and antibiotic use
 59
. After this three-year time point, the matured 
infant microbiome becomes more stable and resilient resembling the adult microbiome
 60
 
The healthy adult intestinal microbiota is dominated primarily by the 
Bacteroidetes and Firmicutes phyla
 61
. The Bacteroidetes are Gram-negative anaerobic 
bacteria, which play critical roles in the metabolism of complex plant polysaccharides 
and are divided primarily into the Bacteroides and Prevotella genera
 62
. The Firmicutes 
are the most diverse phylum in the gut and are a group of Gram-positive, low G+C 
content bacteria, which participate in the production of short chain fatty acids (SCFA) 
and lactic acid fermentation
 61
. This heterogeneous phylum is further divided into the 
Clostridia, Bacilli, and Mollicutes classes, with the anaerobic Clostridia comprising 95% 
of the total Firmicutes. The Clostridia are primarily of the Lachnospiraceae family, 
clusters IV (Clostridium genera) and XIVa (Eubacterium and Ruminococcus genera) and 
most species are producers of the SCFA butyrate
 61,63
. The remaining 5% of the 
Firmicutes are divided into the Mollicutes, and Bacilli classes (Streptococcus, and 
15 
 
 
 
Lactococcus genera). Lactobacillus is a genus of bacteria in the Bacilli class, which has 
potent anti-inflammatory properties and is used as a common probiotic
 11
. Collectively 
the Bacteroidetes and the Firmicutes comprise more than 90% of the bacteria in the gut
 57
.  
The rest of the intestinal microbiota is comprised of the Proteobacteria, 
Actinobacteria, Verrucomicrobia, Fusobacteria, and TM7 phyla along with a predominant 
archael phylotype, Methanobrevibacter smithii. The Proteobacteria are Gram-negative 
aerobic bacteria with a lipopolysaccharide containing outer membrane. Many members of 
this phylum are opportunistic pathogens and infectious organisms, which are seen in the γ 
–Proteobacteria class and the Enterobacteriaceae family (Escherichia, Klebsiella, 
Enterobacter, Proteus, Citrobacter, Salmonella, and Serratia genera). The Actinobacteria 
are Gram-positive bacteria containing the Bifidobacterium genera, another lactic acid 
producing taxa which is also used in probiotic supplementation. There is not much known 
about the composition, presence, and function of the other rare bacterial phyla in the gut. 
Many of these bacteria are unculturable and sequences of these phylotypes were 
discovered during 16s rDNA sequencing experiments. Collectively, the Verrucomicrobia, 
Fusobacteria, TM7, and other unidentified phyla comprise less than 1% of the healthy 
microbial flora.  
Even though the presence of these bacteria has been identified in the healthy 
human gut, there is considerable variation in genera of the predominant phyla, Firmicutes 
and Bacteroidetes, between individuals. It is reported that among different persons, there 
are common core functional capacities but significant interindividual variations of 
16 
 
 
 
bacterial compositions allowing for the classification of three different enterotype 
dominated genera: Bacteroides, Prevotella, or Ruminococcus
 64
. However, it remains to 
be shown the long-term impact these different enterotype dominated microbiotas impart 
on the host’s health and immune function. Classification of the healthy intestinal 
microbiome is clinically necessary for determining normal or abnormal states to elucidate 
how altered microbiota composition may play a role in disease development and 
progression.  
Microbiota and Immune Function 
The intestinal immune system encounters more antigens than any other part of the 
body. Therefore, the recognition of “self” and “non-self” is critical to discriminate the 
harmless commensal microbiota and food antigens from harmful pathogenic microbes. 
This equilibrium in part is established by the balance of effector T cells— the amount and 
function of anti-inflammatory regulatory T cells (Tregs) versus proinflammatory Th17 
cells
 65
. Tregs are a subset of CD4+, CD25+ helper T cells, which express the 
transcription factor FOXP3, secrete IL-10, and maintain tolerance to self-antigens 
protecting against autoimmune diseases
 66
. Th17 cells are another subset of CD4+ cells 
which secrete IL-17A, F, and IL-22 and protect against bacterial infections at mucosal 
surfaces
 67
. These cells cause inflammation and autoreactive Th17 cells have been 
implicated in various autoimmune diseases: inflammatory bowel disease, arthritis, and 
multiple sclerosis. Research has shown that these cells can differentiate and expand 
locally in the gut and then spread systemically to other organs. Antigenic stimulation 
17 
 
 
 
from the intestinal microbiota shapes this balance of Treg/Th17 cells and determines 
homeostasis or inflammation. In the gut, M cells and dendritic cells constantly sample 
microbial antigens from the lumen. The dendritic cells traffic from lymphoid follicles in 
the lamina propria and Peyers patches to the mesenteric lymph nodes to present these 
antigens to naïve CD4+ Th0 cells
 68
. The presentation of specific antigens and production 
cytokines skews and directs the differentiation of Th17, and Tregs. 
The composition of the intestinal microbiota facilitates the development of 
lymphoid organs and directs immune cell responses—the differentiation of adaptive 
immune cells and the production of effector cytokines. Studies using germ free mice, 
mice devoid of any microbes, reveal that these mice are more susceptible to colonization 
by pathogenic microbes, have small and undeveloped lymphoid organs, and show 
reductions in: CD4+ and CD8+ T cells, IgA secretion, and production of AMPs
 47,69,70
. 
Therefore the commensal microbes are essential for regulating immune physiology and 
the innate and adaptive immune systems. Current research is focused on identifying these 
mechanisms and microbial signals that direct immune development and function.  
One specific commensal, Bacteroides fragilis produces a immunomodulatory 
molecule polysaccharide A (PSA) which directs lymphoid organogenesis, modulates the 
Th1 and Th2 balance, directs regulatory T cell development (Treg), and protects against 
models of intestinal inflammation
 8,71-73
. Mazmanian et al. showed that therapeutic 
treatment of PSA led to the production of anti-inflammatory IL-10 and alleviated 
intestinal inflammation in various models of IBD.  
18 
 
 
 
Segmented Filamentous Bacteria, or Candidatus Arthromitus a group of Gram-
positive bacteria related to Clostridia that have not yet been cultured, have been shown to 
attach to small intestine epithelial cells and lead to the production of serum amyloid A 
(SAA). SAA then stimulates dendritic cells in the lamina propria to secrete IL-6 and IL-
23 which promotes Th17 cell differentiation and maturation
 74. Littman’s laboratory 
showed that germ free mice have reductions of Th17 cells in the small intestine but could 
be restored when colonizing mice with feces taken from mono-colonized SFB mice
 74
. 
Therefore colonization of SFB is necessary and sufficient to induce Th17 cell 
differentiation in the gut. Furthermore, they determined the specific membrane bound 
antigenic proteins of the SFB that direct Th17 production
 75
. This bacterial group is also 
necessary for the secretion of IgA and Reg3γ 47. Nevertheless, overgrowth of this bacteria 
may upset the Th17/Treg balance in favor of overactive Th17 cells that can potentially 
lead to autoimmune diseases: inflammatory bowel disease, arthritis, and multiple 
sclerosis
 76,77
.  
Indigenous Clostridium species particularly the spore forming bacteria of clusters 
IV and XIVa, Clostridium leptum and coccoides respectively, are sufficient to induce the 
development of Tregs in the colon
 78
. Colonization of mice with a mix of Clostridium 
strains produced a TGF-β enriched environment, the cytokine necessary for FOXP3 
activation and Treg cell differentiation, and led to Treg cell development in the colon but 
not the small intestine lamina propria. Probiotic therapy of 17 Clostridium strains 
protected against various models of intestinal inflammation and allergies
 79
. These 
19 
 
 
 
commensal bacteria ferment sugars to produce the SCFAs butyrate and propionate which 
act directly on T cells and dendritic cells to inhibit histone deacetylase (HDAC). 
Acetylation of the FOXP3 promoter CNS1 allows for the binding of FOXP3 and 
transcription of Treg dependent genes
 80
.  
Microbiota and Disease 
A person’s intestinal microbiota is largely determined by diet, antibiotic use, 
hygiene, lifestyle, and genetics. Genetic or environment factors may lead to disturbances 
in bacterial communities, or a microbial dysbiosis. These microbial imbalances of the gut 
are seen in numerous disease states: obesity, inflammatory bowel disease, rheumatoid 
arthritis, multiple sclerosis, autism, allergies, diabetes, and others
 81
. Furthermore, it is 
hypothesized that dysbiosis of the intestinal microbiota can lead to disease development 
and progression
 4
. Different diets can leads to variations in intestinal bacteria. A 
“western” diet high in animal fat and protein has been seen to promote a Bacteroides 
dominated enterotype whereas a carbohydrate based diet facilitates a Prevotella 
dominated microbiome
 82
. These diet induced changes in gut bacteria are suggested to 
play a role in obesity, which is seen by a reduction in the Bacteroidetes and an increase in 
the Firmicutes phyla allowing the individual to extract more energy from their food 
 83
. 
Antibiotic use is another example, which can alter the intestinal microbiome. A study that 
examined the changes of the intestinal microbiome in patients following ciprofloxacin 
treatment revealed that antibiotic use changed the diversity and species richness of every 
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patient, and although many communities of bacteria recovered by 4 weeks, there were 
some populations that did not recover up to 6 months after treatment
 84
.  
Therefore certain environmental factors can potentially cause permanent damage 
to the intestinal microbiome. This dysbiosis has the potential to change the antigenic 
variation of the intestinal microbiota leading to an overactive inflammatory response. It is 
hypothesized that when these disturbances occur in genetically susceptible individuals it 
has the potential to lead to inflammatory bowel disease
 85-88
. IBD patients have an altered 
microbial flora seen by a reduction in the Bacteroidetes and Firmicutes and overgrowth 
of the Proteobacteria and Actinobacteria phyla
 89
. More specifically, there are reductions 
in the Lachnospiraceae family, which contain Clostridium clusters IV and XIVa, 
Clostridium leptum and coccoides respectively relative to healthy controls
 63
. These 
protective bacteria produce the SCFA butyrate, a key nutrient for colonocytes and an 
important source for energy production. Butyrate and other SCFAs may enhance the 
epithelial barrier integrity
 89
. Furthermore, a reduction in Faecalibacterium prausnitzii a 
specific species in Clostridium cluster IV, leads to a higher risk of postoperative surgical 
recurrence in IBD patients
 90
. F. Prausnitzii secretes specific factors, which block NF-κB 
activation and increase the secretion of anti-inflammatory IL-10 in the colon
 91
. In 
addition to reductions of protective bacteria there are overgrowths of potentially harmful 
bacteria termed pathobionts
 92. Increases of the γ-Proteobacteria specifically the 
Enterobacteriaceae family are seen concurrently and in relapsing IBD. Specific species of 
the Enterobacteriaceae are sufficient to induce colitis in animal models such as, adherent 
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E. coli, Klebsiella pneumonia, and Proteus mirabilis
 91,93
. Furthermore there are also 
increases of minor phyla of bacteria such as Actinobacteria and TM7, which are also 
suggested to be colitogenic
 94
.  
Probiotic Treatment 
 Restoring the healthy microbiota through probiotic treatment is a potential 
therapeutic intervention that may protect against disease development and progression by 
modulating the immune system. Probiotics are live beneficial bacteria that colonize the 
gut and exert immunological protections through the production of cell surface antigens 
or secreted proteins
 19
. Lactobacilli, Bifidobacteria, E.coli Nissle 1917, Faecalibacterium 
prausnitzii, Bacteroides fragilis, and Bacteroides thetaiotaomicron have all been shown 
to be beneficial groups or strains of bacteria
 4,8,62,90,95,96
. Recent research is focused on 
identifying the protective mechanisms of these bacteria so that they can be combined as 
cocktails and used as treatments to restore the intestinal microbiota and immune function.  
 Various probiotic strains or combinations have shown to be protective in models 
of inflammation, infection, and disease. Bacteroides fragilis has been shown to alleviate 
intestinal inflammation and restore gut permeability protecting against inflammation in 
various models of colitis and autism
 8,97
. E. coli Nissle 1917 has been shown to increase 
tight junction protein levels, human beta-defensin 2 production (hBD-2), and maintain 
remission in ulcerative colitis
 98-100
. VSL #3 is a high concentration prescription 
formulation of 8 bacterial strains consisting of Lactobacilli, Bifidobacteria, and 
Streptococci which is FDA approved for ulcerative colitis, ileal pouch, and irritable 
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bowel syndrome.  This combination of bacteria has been shown to induce IL-10 
production and TGFβ expressing Tcells and is effective in achieving remission in 
ulcerative colitis patients.  
 Lactobacilli are potent protective bacteria that are necessary for immune 
homeostasis in the gut. One specific strain, Lactobacillus rhamnosus GG (LGG), has 
been shown to be protective against intestinal inflammation in models of colitis
 101
. This 
bacteria encodes a SpaC pillin which facilitates its colonization by adhering to mucin 
glycoproteins
 102
. In addition, these pilli interact with TLR2 and play a role in balancing 
IL-8 secretion by intestinal epithelial cells
 103
. It has also been shown that LGG secretes 
soluble proteins, p40 and p75, which act on intestinal epithelial cells to inhibit TNF 
induced apoptosis
 104
. Furthermore, research suggests that LGG may protect against 
pathogenic infections such as E.coli O157:H7 and C. difficile
 105,106
.  
 
 
23 
 
CHAPTER THREE 
MATERIALS AND METHODS 
Animals 
Male C57BL/6 mice, 8-9 week old, weighing 22-25g, were obtained from Charles 
River Laboratories are used in all experiments. Animals were allowed to acclimate to the 
facility for 7-10 days before being used for the experiments. All experiments were 
conducted in accordance with the guidelines set forth by the Animal Welfare Act and 
were approved by the Institution Animal Care and Use Committee at the Loyola 
University Chicago Health Sciences Division.  
Burn Injury Procedure 
Mice were anesthetized with xylazine and ketamine, their dorsal surface shaved, 
and placed in a template exposing ~20% total body surface area (TBSA) as calculated by 
the Meeh formula
 107
. The mice divided into two treatment groups, those receiving burn 
injuries or sham injuries. The burn group were then submerged in a water bath set to 85-
95°C for 7-9 seconds while the sham group were submerged in a water bath set to 37°C. 
Following burn or sham burn, all animals were resuscitated with 1ml of saline. This 
procedure models a severe ~20% TBSA full thickness third degree burn. The animals 
were sacrificed on days 1, 3, and 5 following injury, and intestine tissue and luminal 
contents as well as mesenteric lymph nodes were harvested for downstream experiments.  
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Histology 
 Small, 3-5mm sections of tissue were taken from the ileocecal wall and placed 
immediately in cold Carnoy solution and left to incubate overnight. Paraffin blacks were 
prepared by Loyola University Medical Center Tissue Processing Core, 5μm sections 
were cut, and 1 slide from each animal was H&E stained for tissue pathology. The 
procedure for fluorescent in-situ hybridization staining was performed as described 
previously with minor adjustments
 108
. Slides were deparaffinized by running them 
through 4x 3min incubations in xylene and 4x 3min incubations in absolute ethanol. 
Next, the slides were dried for 25min at 50°C. The indicated probes were diluted to a 
final concentration of 1ng/μl in hybridization buffer (.9M NaCl, 20mMTris-HCL, pH 7.5, 
.1% SDS)
 109
. 500μl of probe in hybridization buffer was placed on the slides and left to 
incubate at 16hr or overnight at 50°C in the dark inside a Tupperware container with 
moist paper towels. The probe sequences were as follows and purchased from Invitrogen
 
12,53,93,109,110
:  
Universal bacterial probe EUB338:  
Alexa 555 5’-GCTGCCTCCCGTAGGAGT -3’ 
Enterobacteriaceae probe ENTBAC 183:  
Alexa 488 5’-CTCTTTGGTCTTGCGACG -3’ 
SFB probe, SFB1008:  
Alexa 488 5’-GCGAGCTTCCCTCATTACAAGG-3’ 
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Following the incubation, the slides were washed 3x for 15min in prewarmed wash buffer 
(.9M NaCl, 20mMTris-HCL, pH 7.5, .1% SDS) at 50°C. The slides were air dried, 
mounted, and counterstained using ProLong Gold Antifade Reagent with DAPI 
(Molecular Probes). The sections were imaged using a Zeiss Axiovert 200m fluorescent 
microscope and images were processed using Axiovision software.  
FITC-dextran assay 
One day after the aforementioned burn or sham injury procedure the mice were 
gavaged with .4ml of 22mg/ml FITC-dextran in PBS. After 3 hours blood was drawn and 
the mice were sacrificed. The blood was centrifuged for 8000rpm for 5min at 4°C, 
plasma isolated, and read spectrophotometrically at 480nm excitation and 520nm 
emission wavelengths.  
Cytokine quantification 
The distal 5cm of the small intestine and the whole large intestine from the cecum 
were collected and sonicated (XL-2000 Misonix) until the solution was homogenous in 
700μl of 1X cell lysis buffer (Cell Signaling Technology) with 1mM PMSF and 1X 
Protease inhibitor added (Cell Signaling Techonology). The homogenates were 
centrifuged at 12,000 RPM for 30min and the supernatant was removed, aliquoted, and 
stored in -80°C for Inflammation Multiplex (Bio-rad), IL-6 (BD), KC (R&D), and Cell 
death ELISAs (Roche). Protein measurements of the same samples were done from Bio-
rad protein assay kit. Data were normalized as amount of cytokine/mg protein.  
RNA and DNA purification 
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Tissue for RNA purification was immediately placed in RNA later (Ambion) and 
left at 4°C overnight before being stored at -80°C. RNA was purified from the tissue 
using Qiagen RNeasy mini-kit with the optional DNase digestion step (Qiagen). cDNA 
was prepared using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). For purification of genomic bacterial DNA, the feces were collected from 
the distal 5cm in small intestine and the whole large intestine from cecum and purified 
using Qiagen DNA stool mini kit with an initial sonication step in lysis buffer ASL and 
the optional high temperature 95°C incubation step to achieve sufficient lysis of both 
Gram-positive and Gram-negative bacteria.  
Real-time PCR 
 Real-time PCR was preformed on mRNA and gDNA to quantify gene expression 
levels and copy numbers of various bacterial groups with the Step One Plus real-time pcr 
machine (Applied Biosytems). Copy numbers do not equal actual bacteria numbers or 
CFU but both are directly related and correlate well
 53
. For gene expression, TaqMan Fast 
Advanced Master Mix (Applied Biosystems) was used along with TaqMan gene 
expression primers and probe for the target gene, and the endogenous control, GAPDH 
(Applied Biosystems). dCT was calculated for each sample of target gene normalized to 
GAPDH and expressed relative to sham as follows:  
Fold=2
(Ct Target-Ct Control)
 
Relative Quantification= (1/fold)*100. 
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For bacterial quantification, purified gDNA was diluted down to 4ng/μl for small 
intestine feces or .4ng/μl for large intestine feces to fall within the range of the standard 
curve. The final qPCR master mix contained 1X iTaq Universal SYBR Green supermix 
(Bio-rad), 3μM forward and reverse primer for the indicated bacterial group see table 1, 
and 24ng (small intestine feces DNA) or 2.4ng (large intestine feces DNA). The reaction 
was run at 95°C for 3min and 40 cycles of 95°C for 15sec and the indicated annealing 
temperature of the primer sets, table 1, for 60 seconds. The data was read at the final step. 
Samples were done in duplicates and standards in triplicate. For standards, purified 
genomic DNA from reference bacteria or plasmids were used. Copies of DNA were 
calculated from the following formula:  
Copies = (g DNA)*(6.022*10
23
copies/mole)/(650g/mol bp)(#bp)  
A standard curve was created from plotting the threshold cycle (Ct) against the  
Copy # of 10 fold dilutions ranging from 10
6
 copies to 1 copy for genomic DNA or 10
7
 to 
10 copies for plasmid DNA. A semilog linear regression line was made and copy # of 
unknowns was calculated from the following formula relating the Ct value for each 
sample to the slope and the y-intercept: 
Copy#= 10
(Ct-b)/m
 
A melt curve was performed for quality assurance and efficiencies ranged under the 
accepted values, 90-110%. Data were normalized as copies of bacterial 16s per gram 
feces, taking into account DNA extraction efficiencies per g feces. 
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Bacterial Primers 
Target Forward Primer 5'-3' Reverse Primer 5'-3' 
Annealing 
Temp (°C) Reference 
Total Bacteria ACTCCTACGGGAGGCAGCAGT ATTACCGCGGCTGCTGGC 63 Barman
 53
 
Bacteroidetes CGAACAGGATTAGATACCCT GGTAAGGTTCCTCGCGTAT 61.5 Bacchetti
 111
 
Firmicutes 
GGAGYATGTGGTTTAATTCGAA
GCA  AGCTGACGACAACCATGCAC  60 Hooper
 109
 
γ-Proteobacteria TCGTCAGCTCGTGTYGTGA CGTAAGGGCCATGATG 61.5 Bacchetti 111 
Enterobacteriaceae GTGCCAGCMGCCGCGGTAA  
GCCTCAAGGGCACAACCTCCAA
G  67 Barman
 53
 
Escherichia coli CATGCCGCGTGTATGAAGAA CGGGTAACGTCAATGAGCAAA 60 Huijsdens
 112
  
Clostridium leptum CCTTCCGTGCCGCAGTTA 
GAATTAAACCACATACTCCACT
GCTT 60 Corthier
 113
  
Clostridium 
Coccoides ACTCCTACGGGAGGCAGC  GCTTCTTAGTCAGGTACCGTCAT  60 Barman
 53
 
Bacteroides GGTTCTGAGAGGAGGTCCC GCTGCCTCCCGTAGGAGT 61 Barman
 53
 
SFB GACGCTGAGGCATGAGAGCAT  GACGGCACGGATTGTTATTCA  58 Barman
 53
 
Lactobacillus AGCAGTAGGGAATCTTCCA  CACCGCTACACATGGAG  56 Barman
 53
 
Actinobacteria TACGGCCGCAAGGCTA TCRTCCCCACCTTCCTCCG 61.5 Bacchetti
 111
 
MIB CCAGCAGCCGCGGTAATA  CGCATTCCGCATACTTCTC  58 Barman
 53
 
Prevotellaceae CCAGCCAAGTAGCGTGCA  TGGACCTTCCGTATTACC  64 Flavell
 94
 
TM7 GCAACTCTTTACGCCCAGT  GAGAGGATGATCAGCCAG  64 Flavell
 94
 
α-Proteobacteria CIAGTGTAGAGGTGAAATT CCCCGTCAATTCCTTTGAGTT 61.5 Bacchetti 111 
Faecalibacterium 
prausnitzii 
CCATGAATTGCCTTCAAAACTGT
T GAGCCTCAGCGTCAGTTGGT 60 Sokol
 114
  
Bifidobacteria CGGGTGAGTAATGCGTGACC TGATAGGACGCGACCCCA 60 Corthier
 113
 
Klebsiella 
pneumoniae AGCACAGAGAGCTTG ACTTTGGTCTTGCGAC 60 Kurupati
 115
 
 
Table 1. List of bacterial primer sequences, annealing temperature, and reference 
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Bacterial Culture 
To culture bacteria from the lymph nodes, the mesenteric lymph nodes were 
aseptically removed, weighed, and homogenized in PBS to achieve a 50mg/ml 
concentration. 50μl of the homogenate was plated on Tryptic soy agar plates with 5% 
sheep blood, and MacConkey agar to grow total and Gram-negative bacteria respectively. 
The plates were cultured aerobically in a 37°C incubator with 5% CO2 for 24 hours.  
Statistical Analysis  
 Data are expressed as mean ± standard error of the mean (SEM) unless otherwise 
noted. Differences between groups were determined by ANOVA with tukey’s post hoc 
test or student’s t-test using GraphPab InStat. P<.05 was considered statistically 
significant. 
 
 
30 
 
CHAPTER FOUR 
RESULTS 
Gross Intestine Pathology 
 We first examined the gross intestine pathology, and the histology by H&E 
staining to observe physical and structural changes to the organ and intestinal villi 
following burn injury. The intestine, specifically the cecum, appeared desiccated, hard, 
and necrotic by gross examination (Fig.1a). H&E staining revealed some blunting of the 
small intestine villi indicative of mild inflammation (Fig.1b).  
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                                   Gross Pathology 
 
 
 
 
 
 
 
                                                     H&E 
 
 
 
 
 
 
 
 
 
 
Figure 1 Necrotic intestine tissue and mild blunting of the small intestine villi one day 
post burn injury. a. depicts gross intestine pathology and b. reveals histology of the distal 
small intestine by H&E staining in a representative sham and burn animal (20X 
magnification).  
Sham One day after burn 
a. 
b. 
32 
 
 
 
Expression of AMPs following burn injury 
We next determined the expression of AMPs in the gut after burn injury. The role 
of α-defensins and C-type have been previously described in other studies to play a 
significant role in epithelial barrier defense and regulating the intestinal microbiota in the 
distal small intestine, however it is not known how burn injury alters the expression of 
these proteins
 47,49,50,55,56,116,117
. Therefore we measured the levels of mRNA expression of 
five various α-defensin genes, Defcr1, CR2, Defcr5, Defcr21, and Defa-rs1 and two C-
type lectins, Reg3γ and Reg3β by reverse transcription qPCR in the distal small intestine 
one and three days after burn or sham injury. We observed a 40-50% reduction of all the 
α-defensins in the small intestine one day after injury relative to the sham group, p<.05 
ANOVA (Fig. 2). These reductions normalized to sham levels three days after injury. The 
α-defensin mRNA levels in the large intestine tissue were undetectable (data not shown). 
This is most likely due to the fact that Paneth cells are the primary producers of these 
proteins and these specialized cells are found specifically in the small intestine
 118
. 
Concerning the C-type lectins, Reg3γ expression displayed a 50% reduction three days 
after injury in the tissue relative to sham, p<.05 ANOVA (Fig. 2). Reg3β levels were not 
significantly different when analyzed by ANOVA but showed a significant decrease 
when comparing days three post burn with sham by an unpaired student t-test, p<.05 
(Fig2).  
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Figure 2. Burn injury suppresses α-defensin and C-type lectin expression one and three 
days after injury respectively. RNA was purified from the distal small intestine, reverse 
transcribed to cDNA, and quantitated by qPCR using primers and probes specific for the 
target gene and an endogenous control. AMP expression was normalized to GAPDH by 
the ΔCt method and expressed relative to sham. Values are mean ± SEM from 7-15 
animals/group. *, p <0.05 ANOVA and Tukey’s post hoc test burn day 1 or 3 compared 
to sham. #, p<.05 unpaired t-test burn day 3 compared to sham.  
 
 
Burn Injury and the Intestinal Microbiota 
 Reductions of AMPs in the intestine have been shown to accompany disturbances 
in bacterial communities, thus we asked whether the intestinal microbiota was changing 
on days one and three following injury to mirror the changes we observed in the α-
defensins and C-type lectins
 12
. To quantify changes in the predominant bacterial groups 
of the gut we used primers for 16s, the gene for the small bacterial subunit, which have 
been previously designed and validated (see table 1). 16s is a gene contained by all 
prokaryotes that is highly evolutionarily conserved but contains enough nucleotide 
variability necessary to determine different phylogenetic bacterial lineages
 119-121
. We first 
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asked if burn injury led to changes in total bacterial load in the feces of the small and 
large intestine. The data revealed a 23-fold increase in the small intestine one day after 
burn relative to sham but no significant changes in the large intestine (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Burn injury leads to increases in total bacteria content in the small intestine 
but not the large intestine one day after injury. Genomic bacterial DNA was purified 
from the feces of the small (a) and large (b) intestine and quantified by qPCR using 
universal bacterial primers. Copies of 16s were calculated based on a standard curve 
normalized to gram feces and expressed relative to sham. Values are mean ± SEM from 
5-9 animals/group. *, p <0.05 burn day 1 compared to sham ANOVA and Tukey post hoc 
test. 
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 In addition, we examined the bacterial diversity of the intestinal microbiome with 
focus on the most abundant bacterial groups in the healthy intestine and key bacterial 
groups that have pro-inflammatory or anti-inflammatory potential in burn patients or 
other inflammatory diseases. In the small intestine, we observed no change in the most 
abundant bacterial phyla, the Gram-positive Firmicutes and Gram-negative Bacteroidetes, 
but saw an enormous increase, ~1300 fold in the Gram-negative aerobic γ-Proteobacteria 
class, one day after burn relative to sham animals (Fig. 4a). Furthermore within the γ-
Proteobacteria class, we observed an ~4000 fold increase of Enterobacteriaceae and 
~3000 fold increase in E. coli on the same day post injury (Fig. 4a). Segmented 
filamentous bacteria and Lactobacillus were significantly decreased in the small intestine 
feces three days after burn relative to sham (Fig. 4a). Astonishingly, every bacterial group 
we measured in the large intestine showed a significant change one day after burn relative 
to sham. These changes were more diverse but less intense than the changes of bacteria in 
the small intestine. Concerning the major taxa, there was a significant increase in the 
Bacteroidetes and a reciprocal decrease of the Firmicutes (Fig. 4b). Of the prominent 
genera and species of bacteria within these phyla, the Bacteroides a genus within the 
Bacteroidetes, was similarly elevated and Clostridium leptum and coccoides, prominent 
species within the Firmicutes, were significantly reduced (Fig. 4b). Furthermore similar 
to the small intestine, the γ-Proteobacteria, Enterobacteriaceae, and E. coli were all 
significantly elevated and were some of the most pronounced changes of any bacterial 
groups (Fig. 4b). In addition, the Enterococcus genus and Enterococcus faecalis species 
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were increased ~12 and 76 fold respectively (Fig. 4b). Another minor phyla, the Gram-
positive Actinobacteria, were significantly elevated in the large intestine (Fig. 4b). These 
bacterial changes are summarized in table 2. 
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Figure 4. Burn injury alters the intestinal microbiome one or three days after injury 
relative to sham. Genomic bacterial DNA was purified from the feces of the small (a) and 
large (b) intestine and quantified by qPCR using bacterial primers for the indicated group. 
Copies of 16s were calculated based on a standard curve normalized to gram feces and 
expressed relative to sham. Values are mean ± SEM from 5-9 animals/group. *, p <0.05 
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burn day 1 compared to sham ANOVA and Tukey post hoc test. #, p<.05 Burn day 3 
compared to sham student t-test.  
 
Small Intestine 
Bacteria Burn Day 1 Burn Day 3 
Bacteroidetes 13.43156523 3.168774817 
Firmicutes 4.509607998 2.76553264 
γ-Proteobacteria 1311.641382 9.617735076 
Enterobacteriaceae 4373.958842 3.470150519 
E coli 2773.74232 1.009265903 
SFB 4.050059795 0.269216568 
Lactobacillus 3.100998444 0.055341709 
Bacteroides 7.077855859 0.145702064 
 
 
Large Intestine 
Bacteria Burn Day 1 Burn Day 3 
Bacteroidetes 1.560458447 0.918091502 
Firmicutes 0.498545375 0.913628514 
Actinobacteria 2.791485255 0.758732414 
γ-Proteobacteria 13.09717634 1.27834003 
α-Proteobacteria 0.421522628 0.515118647 
Enterobacteriaceae 422.003233 0.590892167 
E. coli 358.356581 0.846018583 
Lactobacillus 5.094663852 1.225964372 
Bacteroides 1.489482089 0.847025692 
C. leptum 0.591921874 0.641444577 
C. coccoides 0.376238227 0.697278436 
Enterococcus 12.65069407 2.069339532 
Enterococcus 
faecalis 76.77106235 1.013609503 
 
 
Table 2: Fold change of copies 16s/g feces relative to sham levels of the indicated 
bacterial group in the small or large intestine feces one and three days after injury.  
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Fluorescent in-situ hybridization  
 Using qPCR for 16s we identified an ~4000 fold increase in Enterobacteriaceae in 
the small intestine feces and an ~400 fold increase in the large intestine feces (Fig. 4a,b). 
Other studies have reported that the Enterobacteriaceae is a potentially proinflammatory 
group of bacteria that contains many opportunistic pathogens which may overgrow in 
response to inflammation and induce colitis
 93,122
. This family of bacteria comprises a 
minor part of the healthy intestinal microbiota and is rarely found adhering to the 
intestinal villi
 123
. Adherence of these bacteria to intestinal epithelial cells is necessary for 
these bacteria to induce intestinal inflammation or translocate to extraintestinal organs. 
Therefore, to visualize the proximity of these bacteria to the intestinal villi we stained the 
16s rRNA of this bacterial group by fluorescent in-situ hybridization (FISH). Using a 
universal bacterial probe in combination with an Enterobacteriaceae specific probe, we 
detected overgrowth of Enterobacteriaceae adjacent to the epithelium in the small 
intestine one day after injury in the burn animals but not the sham (Fig. 5). This suggests 
that the Enterobacteriaceae may have invasive potential and the ability to induce 
inflammation by activating pattern recognition receptors present on the intestinal 
epithelial cells.  
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Burn Day 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Burn injury leads to an increase of Enterobacteriaceae adjacent to the small 
intestinal villi one day after insult. Red represents Alexa 555 EUB probe for total 
bacteria. Green represents Alexa 488 Entbac probe for Enterobacteriaceae. Orange 
depicts colocalization of both probes and the Enterobacteriaceae. Blue is a DAPI stain for 
nuclei. The above image is 100x magnification.  
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Intestinal Inflammation  
 
 Dysbiosis of the microbiota has been previously shown to potentiate intestinal 
inflammation in IBD
 124
. Therefore we asked whether burn-induced changes in the 
intestinal microbiome that we observe one or three days after injury accompanies 
increases of inflammatory cytokines and apoptosis. To test this hypothesis we ran a 
multiplex assay on inflammatory cytokines in both the small and large intestines. 
Numerous innate cytokines and chemokines were increased in both the small and large 
intestine one day after injury. To confirm these results, we next ran ELISA’s on two key 
inflammatory markers of burn injury IL-6 and KC. Both IL-6 and KC were significantly 
elevated in the small intestine one day after burn but only KC was increased in the colon 
(Fig. 6 a-d). Inflammation has the potential to be detrimental to the host and lead to 
increases of cell death. Thus, we ran a cell death apoptosis ELISA and noted increases in 
apoptosis both one and three days after injury in the small intestine (Fig. 7). Therefore, 
we noticed that burn injury is leading to increases in intestinal inflammation in both the 
small and large intestines one day post burn and increases of apoptosis in the small 
intestine one and three days post burn.  
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Figure 6. Burn injury leads to an increase of cytokines in the small and large intestine. 
Total small and large intestine tissues were homogenized. IL-6, and KC ELISAs were 
performed on sham, burn day one, and burn day three on the small intestine (a,c) or the 
large intestine (b,d).*, p<.05, ** p<.01, *** p<.001 burn day 1 compared to sham, 
ANOVA and Tukey multiple comparison tests. Values are all expressed as mean ± SEM 
8-11 animals per group.  
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Figure 7. Burn injury leads to an increase of cell death in the small intestine. Total small 
intestine tissue was homogenized. A cell death ELISA was performed on sham, burn day 
one, and burn day three on the small intestine. Data is expressed as OD value at 450nm 
per mg protein for each sample. *, p<.05, ** p<.01, burn day 1 or 3 compared to sham, 
ANOVA and Tukey multiple comparison tests. Values are all expressed as mean ± SEM 
8-11 animals per group.  
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Intestinal Permeability 
 In order to determine whether an increase of intestinal inflammation accompanied 
an increase of gut leakiness following burn injury, we ran a FITC-dextran permeability 
assay. Mice were gavaged with FITC-dextran one and three days after burn. Three hours 
later, blood was drawn and the concentration of this fluorescent conjugated sugar moiety 
was determined spectrophotometrically. In normal physiologic conditions, the size of this 
molecule prevents its translocation from the intestinal lumen into the circulation. The 
concentration of FITC-dextran increased in the plasma one day after burn relative to the 
sham animals (Fig. 8a). In addition to the FITC-dextran assay, we quantified the gene 
expression of two tight junction proteins, claudin 4,8 in the small and large intestine. We 
saw a 50% reduction in claudin 4, and 8 in the small intestine but no change in the large 
intestine (Fig. 8b,c).  
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Figure 8. Increases of intestinal permeability one day after burn injury. a. represents the 
FITC-dextran permeability. Mice were gavaged with FITC-dextran one and three days 
after burn or sham injury. Three hours later the concentration of this dye was measured 
spectrophotometrically in the plasma of the mice. b. and c. represent RT-qPCR from the 
distal small intestine or large intestine, using primers and probes specific for the target 
gene and an endogenous control. TJ expression was normalized to GAPDH by the ΔCt 
method and expressed relative to sham. Values are mean ± SEM from 5-10 
animals/group. *, p <0.05 ANOVA and Tukey’s post hoc test burn day 1 to sham.  
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 Increased gut leakiness has been shown to lead to bacterial translocation to the 
lamina propria and the mesenteric lymph nodes (MLN)
 28
. Therefore we asked whether 
increases in gut bacteria could be leading to increases of bacterial translocation. We first 
stained for total bacteria by FISH and noticed bacteria in the lamina propria of the small 
intestine after burn injury (Fig. 9). Furthermore, we measured total bacteria and 
Enterobacteriaceae in the MLN by qPCR and culture methods. We found that burn injury 
resulted in a significant increase in total bacteria and Enterobacteriaceae in the MLN by 
qPCR one day after injury (Fig. 10). In addition, bacteria were cultured aerobically on 
tryptic soy agar (TSA) with 5% sheep blood, to identify total aerobic bacteria, and 
MacConkey agar, to identify Gram-negative aerobic bacteria or the Enterobacteriaceae 
for 24hrs. We noted a significant increase of colonies present on the TSA and 
MacConkey plates from burn day one animals and no colonies were observed on the 
plates from the sham animals (Fig. 11b). Some colonies were also detected on the TSA 
plates three days after burn (Fig 11c). Collectively this data shows that the intestinal 
permeability increases one day after injury, and this permeability may be due to 
alterations in tight junction proteins. This increased gut leakiness leads to bacterial 
translocation to the lamina propria and the MLN seen one or three days after burn. 
Furthermore, we observed bacteria present in the MLN and most of these bacteria were 
Enterobacteriaceae. Therefore, burn injury leads to an overgrowth of Enterobacteriaceae 
in the small and large intestines that occurs one day after burn and has the potential to 
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spread systemically to other organs. Systemic Gram-negative bacteremia has the potential 
to lead to sepsis and multiple organ failure for burn patients.  
 
 
 
Figure 9. Bacteria present in the small intestine lamina propria one day after burn. Red 
represents Alexa 555 EUB probe for total bacteria. Blue is a DAPI stain for nuclei.  
 
 
 
 
 
 
 
Universal Bacterial Probe 
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Figure 10. Total bacteria and Enterobacteriaceae in the MLN one and three days after 
injury. MLN were removed from sham burn day 1, and burn day three animals. The 
tissue was homogenized, total DNA was purified from the tissue, and qPCR was 
performed on the DNA using universal bacterial primers and primers specific for 
Enterobacteriaceae (table1). Data is expressed as qPCR copies bacteria/ng total DNA 
relative to sham. Values are mean ± SEM n=6 animals per group. ANOVA and Tukey 
post hoc test *,p<.05 burn day 1 or burn day 3 compared to sham. 
* 
* 
0
1
2
3
4
5
6
7
8
9
sham Burn Day 1 Burn Day 3
C
o
p
y
#
 1
6
s/
n
g
 t
o
ta
l 
D
N
A
 
(R
el
a
ti
v
e 
U
n
it
s)
 
Total Bacteria 
* 
* 
0
5
10
15
20
25
30
35
Sham Burn Day 1 Burn Day 3
C
o
p
y
#
 1
6
s/
n
g
 t
o
ta
l 
D
N
A
 
(R
el
a
ti
v
e 
U
n
it
s)
 
Enterobacteriaceae 
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Bacteria in the MLN one or three days after burn. The lymph nodes were 
aseptically removed from sham (a) burn day 1 (b) or burn day 3 (c) animals and 
homogenized in PBS to achieve a 50mg/ml concentration. Equal volume for each sample 
was plated on tryptic soy agar plates with sheep blood or MacConkey agar plates and 
cultured aerobically for 24 hours to grow total bacteria or Enterobacteriaceae 
respectively. The above plates are a representative image taken from one sham animal, 
one burn day one, and one burn day three.  
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Probiotic Treatment 
 Probiotic treatment with live beneficial bacteria has shown promise in restoring 
the epithelial barrier and preventing intestinal inflammation in various models of disease
 
8,95,97,104
. Lactobacillus rhamnosus GG (LGG) is a probiotic strain which adheres to 
intestinal mucins and secretes various factors which increase epithelial cell proliferation, 
regulate tight junction expression, and modulate cytokine secretion
 11,18,96
. Previous 
research has shown that LGG is an effective therapy for reducing intestinal inflammation 
in models of colitis. This efficacy was achieved by oral inoculation of 10
10
 colonies/ml of 
LGG
 95
. Therefore we decided to treat mice with 10
10
 colonies/ml of LGG by gavage at 
the time of injury and measure various parameters associated with gut barrier 
dysfunction—antimicrobial peptide production, tight junction expression, and 
inflammatory cytokine levels. To perform this experiment, mice were divided into four 
groups, sham vehicle, burn vehicle, sham plus lactobacillus, and burn plus lactobacillus. 
Immediately before injury mice were given a gavage of 0.2ml of PBS or LGG. The mice 
were then sacrificed one day after injury; the time point where we see the most 
pronounced changes.  
 We used real-time qPCR to measure α-defensin expression one day after injury in 
the small intestine and chose to focus on a single defensin gene, defa1. Relative to sham 
vehicle, we saw a 40% reduction in burn vehicle, which indicates consistent observations 
to what was earlier reported (Fig. 12). There was no change in gene expression of defa1 
in sham lacto. relative to sham vehicle suggesting that LGG does not modulate the α-
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defensin gene expression in the wild type sham animals. However the burn lacto group 
showed 57% reduction in defa1 relative to sham vehicle a similar result to what was 
reported in the burn vehicle (Fig. 12). Therefore, this experiment showed us that at this 
concentration and time point LGG did not restore α-defensin expression.  
 We next measured whether LGG restored the expression of a key tight junction 
protein cldn4, which we previously observed down in the small intestine one day after 
burn. This experiment revealed similar results to what we observed in defa1, there was a 
decrease in burn vehicle, no change in sham lacto, and a decrease in burn lacto 
suggesting that this experiment did not restore expression of cldn4.   
 Previously we observed significant increases of KC in the small intestine 
following burn injury, and there is data suggesting LGG may decrease expression of this 
cytokine in models of colitis. However, it has not been determined whether this 
therapeutic may be protective in burn injury. Therefore, we measured KC production in 
the small intestine following LGG treatment to investigate whether this probiotic may 
reduce intestinal inflammation following burn (Fig. 13). We saw no reduction of KC in 
the lactobacillus treated burn group in the small intestine one day after injury. Therefore 
the 10
10
 CFU/ml dose of LGG did not show any therapeutic benefit with regard to α-
defensin or tight junction expression, and KC levels in the small intestine one day after 
injury.  
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Figure 12. LGG treatment does not restore α-defensin 1 or claudin 4 expression in the 
small intestine one day after burn injury. RNA was purified from the distal small 
intestine, reverse transcribed to cDNA, and quantitated by qPCR using primers and 
probes specific for α-defensin 1 or claudin 4 and an endogenous control. Gene expression 
was normalized to GAPDH by the ΔCt method and expressed relative to sham. Values 
are mean ± SEM from 7-10 animals/group. *, p <0.05 ANOVA and Tukey’s post hoc test 
burn vehicle or burn lacto. compared to sham vehicle.  
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Figure 13. LGG treatment does not restore KC levels one day after burn injury in the 
small intestine. Total small intestine tissue was homogenized and KC concentration was 
measured by ELISA on sham vehicle, burn vehicle, sham lacto, and burn lacto groups. 
Values are all expressed as mean ± SEM 7-10 animals per group. *, p<.05 burn vehicle or 
burn lacto compared to sham vehicle, ANOVA and Tukey multiple comparison tests.  
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CHAPTER FIVE 
SUMMARY AND DISCUSSION 
 Multiple organ failure and sepsis are the leading complications contributing to 
post burn morbidity and mortality in patients who sustain thermal injuries
 1
. Identifying 
the contributing factors and mechanisms leading to a dysregulated immune response, 
which predisposes patients to second hit infections, is necessary to develop novel 
therapeutics to prevent sepsis and organ failure. Overgrowth of specific gut bacteria and 
gut barrier disruption may play a role in generating a systemic inflammatory response—
the principal etiological factor contributing to sepsis
 5,6,125
. Therefore, it is necessary to 
determine whether burn injury influences the intestinal microbiota and whether the 
change in the microbiome is related to gut barrier dysfunction following burn injury. We 
hypothesized that burn injury leads to a decrease in AMPs which allow for changes in the 
intestinal microbiota that contribute to increases of inflammation and permeability in the 
intestines. Our findings reported herein suggest that burn-mediated increase in gut 
leakiness could result from a potential change in the microbiota. We further observed an 
increase in intestinal inflammation, gut leakiness, and bacterial translocation to 
extraintestinal sites. This translocation of bacteria into the circulation may potentiate a 
systemic inflammatory response that may then lead to sepsis.  
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 The host regulates various species and abundances of microbes in the intestine 
through the production of antimicrobial peptides. Antimicrobials are constitutively 
secreted primarily by the Paneth cells of the small intestine, and two classes of AMPs, α- 
defensins and C-type lectins, have been shown to be critical in maintaining normal 
proportions of bacteria and homeostasis in the intestine
 50,53
. Since, it is not known how 
these AMPs respond following burn injury we measured the expression of these proteins 
in the small intestine and found that α-defensins, Reg3γ, and Reg3β decreased one and 
three days after injury respectively. Unlike humans who express two different isoforms of 
Paneth cell α-defensins, HD-5 and -6, mice express highly polymorphic structurally 
similar proteins termed cryptdins
 126
. To date, there have been 17 different cryptdins that 
have been identified and only six of which have been purified
 127
. Cryptdins 1-4 possess 
the most microbicidal activity but the specific role each of these peptides have in vivo is 
unclear
 128
. Thus further research is needed to determine the various immunological 
functions of the α-defensins in the intestine following burn injury.  
 Although, the mechanisms leading to the release of α-defensins are largely 
unknown, α-defensins have been shown to be downstream of toll-like receptor or NOD-
like receptor pathways
 54
. Further research is needed to determine why expression of 
these proteins decreases following burn injury and whether burn induces the production 
of unknown ligands which interact through these pattern-recognition receptors to inhibit 
AMP production. On the other hand, it is known that Reg3γ and Reg3β secretion is 
regulated through SFB and the IL-22 pathway
 74,129
. SFB interact with intestinal epithelial 
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cells to lead to the production of serum amyloid a (SAA). SAA then acts on dendritic 
cells to promote Th17 cell differentiation
 74
. Th17 cells secrete IL-22 which acts on the 
IL-22R expressed exclusively on intestinal epithelial cells which leads to the production 
of AMPs such as Reg3γ and Reg3β 129. We see decreases of IL-17 and SFB three days 
after burn which may explain why Reg3γ and Reg3β are also down three days after 
injury. Another potential mechanism leading to antimicrobial decrease is that burn 
induces a hypoxic environment in the intestine and this lack of oxygen may lead to 
apoptosis. We observed an increase of apoptosis in the small intestine one and three days 
after injury, and this cell death may explain why we noticed decreases of α-defensins and 
C-type lectins on these days respectively.    
 Mouse cryptdins and C-type lectins may be differentially transcribed or possess 
varying functions than their human homologous counterparts
 118,130,131
. Therefore, the 
levels and functions of human α-defensins and C-type lectins need to be investigated as 
well. To study the in vivo roles of these AMPs, α-defensin and Reg3γ knockout mice 
have been created as well as transgenic mice overexpressing human HD-5 in intestinal 
epithelial cells
 50,55,132
. It would be interesting to determine whether the AMP specific 
knockouts have increased mortality, morbidity, intestinal inflammation, gut leakiness, 
and microbiota changes than the wild type mice have after burn injury. In addition, it is 
crucial to determine whether the α-defensin overexpressing mice are protected from burn 
induced complications as compared to the wild type mice. If so, these experiments would 
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provide support that AMPs could be used as a novel potential therapeutic to prevent 
infections for burn patients.  
 We hypothesized that it is this decrease of AMPs which allows for changes in the 
intestinal microbiota. However, there are many other factors which could be contributing 
to these changes. For instance, nutrient abundance is a key factor that contributes to niche 
specific bacterial communities
 133
. Disruption of a continual nutrient supply may allow 
for colonization by foreign pathogens or expansion of underrepresented bacterial species 
which can outcompete the other commensals
 134,135
. After the burn injury, the mice 
become less active and are less likely to eat, and this change in diet, may allow for 
changes in the bacterial flora. In addition, burn injury may change the physiologic 
oxygen levels of the gut which could potentiate expansions of aerobic and reductions of 
anaerobic bacteria. We observed increases of aerobic γ-Proteobacteria and 
Enterobacteriaceae, but decreases in the anaerobic Firmicutes and Clostridia one day after 
injury. Research shows that following burn there is a mesenteric vasoconstriction which 
reduces blood flow and creates an ischemic environment in the intestines
 136
. After some 
elapsed time, the blood flow vigorously returns and this reperfusion creates an oxygen 
rich environment
 137
. The earliest time point we studied was one day after injury, and we 
do not know the levels of oxygen in the intestine at this time point. It would be interesting 
to determine whether the increases of Gram-negative aerobic bacteria also occur at earlier 
time points. In addition, if we reduce blood flow through ligation of the carotid artery, do 
we still observe similar changes in the microbiota? Any factor, which alters the normal 
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physiological habitat of the bacteria, may play a role in inducing changes in the 
microbiota. In vivo, numerous factors in addition to changes in AMPs most likely impart 
a certain magnitude in altering the intestinal microbiota, but further research is needed to 
identify these variables. 
 To explore the changes in the intestinal microbiota, we used qPCR of the 16s 
gene for the bacterial ribosome with various primer sets that have been previously 
designed and validated (Table 1) which amplify select bacterial taxa
 119
. Concerning the 
major taxa, we observed increases in only the γ-Proteobacteria in the small intestine 
feces. However the large intestine showed more diverse but less intense changes—a 
decrease in the Firmicutes and an increase of the Bacteroidetes and γ-Proteobacteria one 
day after burn. Next, we explored various families, genera, and species within these 
taxonomic groups that are either in high abundance in the gut, or that have been shown to 
be potentially protective or harmful. In both the small and large intestine the bacterial 
group that showed the most exaggerated change was the Enterobacteriaceae family. This 
family of bacteria is under the γ-Proteobacteria class and contains many opportunistic 
pathogenic bacteria such as the Escherichia, Proteus, Salmonella, and Klebsiella genera
 
93
. Furthermore, we noticed increases in E. coli in both the small and large intestines. 
Overgrowth of Enterobacteriaceae has been shown to cause intestinal inflammation and 
increased gut permeability in models of colitis
 138
. Furthermore, the proportions of these 
bacteria are increased in the intestines of inflammatory bowel disease patients and in 
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patients that present relapsing recurrent Crohns disease
 139
. Therefore this bacterial group 
may also be harmful for burn patients.  
 Concerning the protective bacteria, we noticed decreases in Clostridia, 
Clostridium leptum or Clostridium coccoides, in the large intestine one day after burn. 
These bacteria have been shown to induce Treg cell differentiation and decrease intestinal 
inflammation in models of colitis
 78,79,140
. A decrease in Treg cell numbers or function 
may explain the intestinal inflammation that we see one day after burn. These bacteria 
produce the short chain fatty acids butyrate and propionate which acts on dendritic cells 
and CD4+ T cells to increase the differentiation of Tregs
 80. These SCFA’s also act on 
colonic epithelial cells to increase cell proliferation. A decrease in these bacteria along 
with their SCFA metabolites may offer additional therapeutic interventions to reduce 
intestinal inflammation in burn injured patients.  
 We also detected decreases in segmented filamentous bacteria three days after 
injury in the small intestine feces. These bacteria produce various cell surface antigens 
which selectively lead to Th17 cell maturation in the small intestine lamina propria
 75,141
. 
Previously our lab has shown that Th17 cells have a protective function regulating the gut 
barrier in burn injury by inducing AMP production and preventing pathogenic bacterial 
infections
 7,142
. Therefore SFB bacteria may serve a protective role in burn injury by 
increasing Th17 cell counts and effector cytokines. It remains to be determined whether 
reconstituting the gut with these bacteria could boost the adaptive immune response and 
prevent immunosuppression and infectious complications in burn patients.  
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 Another potentially protective bacteria that we observed decrease in the small 
intestine three days after injury were the Lactobacilli. There are numerous protective 
strains of these bacteria which modulate the innate immune system through various 
mechanisms
 11
. This genera of bacteria adheres to the inner mucous layer and interacts 
with TLR2 with their pilli
 18
. In addition, these bacteria secrete factors, p40 and p75, 
which increase tight junction protein expression and inhibit apoptosis of the intestinal 
epithelial cells
 104
. Various strains of lactobacillus have been shown to reduce intestinal 
inflammation and be protective in models of IBD, however more research is needed to 
determine which strains may confer protection in burn patients.  
 Microbial dysbiosis has been suggested to lead to intestinal inflammation and 
permeability in various diseases: IBD, obesity, diabetes, rheumatoid arthritis, and autism
 
143
. This led us to question whether microbial dysbiosis was also involved in burn injury 
and may be contributing to similar increases of intestinal inflammation and permeability. 
We therefore measured intestinal inflammation and permeability one and three days after 
injury—the same days we observed changes in the bacterial flora of the small or large 
intestines. We saw an increase in innate cytokines, IL-6 and KC, in the small intestine 
one day after injury. In addition we ran an in vivo FITC-dextran gut permeability assay 
and observed increases in intestinal permeability also one day after injury. Furthermore 
we wanted to determine whether the increased intestinal permeability could be leading to 
bacterial translocation to the lamina propria or extraintestinal sites
 144
. Since we noted the 
highest increases in Enterobacteriaceae in both the small and large intestine feces, we 
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decided to stain this family of bacteria with FISH to visualize their location in relation to 
the intestinal epithelial cells—a place where these bacteria are not usually found in the 
healthy microbiome
 93
. We showed that Enterobacteriaceae were found adjacent to 
intestinal villi which suggests that these bacteria may possess invasive potential. We next 
measured this bacteria in the MLN by culture and qPCR and noted increases of viable 
bacteria in the lymph nodes both one and three days after injury. These data suggest that 
Enterobacteriaceae are able to overgrow in the intestines after burn and translocate to 
extraintestinal sites. 
 Enterobacteriaceae are Gram-negative bacteria containing LPS on their bacterial 
cell wall. LPS binds to TLR4 and activates downstream transcription factors which 
upregulates the production of inflammatory cytokines
 145
. Therefore the increase of 
Enterobacteriaceae that we detected may be causing inflammation through this signaling 
pathway. Previous work has shown that signaling through the TLR4 pathway is harmful 
but TLR2 is protective after burn injury
 146
. Changes in the intestinal microbiota may help 
to explain this phenomenon. Gram-positive bacteria contain a peptidoglycan cell wall 
which is a ligand for TLR2. We noted decreases of Clostridia the predominant Gram-
positive bacterial group in the gut. Therefore a combination of a loss of protective 
Clostridia and pathogenic Enterobacteriaceae may explain the increases of inflammation 
in the intestines following burn. An increase of intestinal inflammation can lead to cell 
death and an apparent breakdown of the epithelial barrier allowing for bacterial 
translocation. In addition to inflammation and permeability we also noted increases of 
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apoptosis in the small intestine both one and three days after injury. Further research is 
still needed to determine whether the Enterobacteriaceae are indeed causing inflammation 
in the intestines. Knocking down the Enterobacteriaceae group through selective 
antibiotic treatment with polymyxin B and Clostridia through a vancomycin and 
metronidazole combination will determine the role these bacteria play in the intestines 
following burn injury. 
 Probiotic therapy has shown promise in reducing intestinal inflammation in 
models of colitis. Therefore we tested whether a probiotic supplement of Lactobacillus 
rhamnosus GG could restore the epithelial barrier by increasing AMP production, 
increasing tight junction protein expression, and reducing intestinal inflammation one day 
after burn injury. We gavaged mice with 10
10
 CFU/ml of bacteria at the time of injury 
and measured these parameters. Previous research has shown that this bacteria secretes 
factors, p40 and p75, which increase tight junction protein expression and reduce 
intestinal inflammation in models of colitis but it is not yet determined whether this 
bacteria is protective in burn
 101,104
. However, we did not see a change in α-defensin 1 or 
cldn 4 expression nor a reduction in KC or IL-6 production. These results could be due to 
numerous factors. First, it is possible that 24 hours is not enough time for this bacteria to 
adhere to the inner mucus layer, colonize the intestine, and exert its protective effects. It’s 
also possible that 10
10 
CFU/ml may not be a high enough dose for protection in burn 
injury as opposed to colitis models. Another possibility may be that this bacterial strain is 
simply not protective in burn injury and that other probiotic alternatives need to be 
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explored. Probiotic therapy still remains a novel therapeutic avenue which may modulate 
the immune system, fix the intestinal epithelial barrier, and prevent gut bacteria from 
becoming a source of septic infections or organ failure.  
 Sepsis and multiple organ failure remain the leading problems associated with 
post burn complications. Therefore it is crucial to elucidate the scientific mechanisms 
leading to these disease pathologies. Previous burn research has suggested that 
translocating gut derived factors may potentiate a systemic inflammatory response
 5
. 
Nevertheless, the mechanisms leading to this phenonmenon remain largely unexplored. 
This is the first study which suggests that burn injury induces a microbial dysbiosis which 
may play a role in propagating intestinal inflammation, and gut leakiness. We showed 
that specific gut bacteria, Enterobacteriaceae, overgrow in response to injury, and can 
translocate to extraintestinal sites such as the MLN. Previous research has suggested a 
link between Gram-negative infection and sepsis
 35
. Therefore elevations of this family of 
bacteria may be potentially problematic for burn patients and increase the risk for sepsis. 
More research is necessary to elucidate the mechanisms of Enterobacteriaceae 
translocation to the MLN and activation of inflammatory pathways. In addition, this 
study suggests that reducing the Enterobacteriaceae to normal physiological levels 
through the use of probiotic cocktails or antimicrobial therapy may be potentially 
beneficial to burn patients.  
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SPECIFIC METHODS 
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Mouse Model of Thermal Injury 
 
 Adult C57BL/6 mall mice (7-8 weeks old, 22-25g body weight, Charles River 
Laboratories) were chosen randomly for all experiments. Animals received sham or burn 
injury yield two groups. For the LGG treatment, animals were divided into four groups 
sham PBS, burn PBS, sham LGG, and burn LGG. The mice were anesthetized with a 
intraperitoneal injection of ketamine hydrochloride/ xylazine cocktail (~80mg/kg and 1.2 
mg/kg, respectively). The dorsal surface was shaved and the mice were transferred to a 
template calculated to expose ~20% TBSA as calculated by the Meeh formula, A=kW
2/3
, 
given k=10, and weight in grams
 107
. The mice were submerged in a water bath set to 
85°C for 7-9 seconds to emulate burn injury or a water bath set to 37°C to emulate sham 
injury. Following the burn the mice were resuscitated with an intraperitoneal injection of 
1ml of saline. Animals were allowed food and water ad libitum. Mice were sacrificed and 
organs or tissue were collected one or three days after injury.  
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qPCR 
For quantification of gene expression, RT-qPCR 
RNA Purification 
1. RNA was purified using RNeasy mini kit by Qiagen. 
2. Tissue stored in RNA later was excised, 20 mg, and homogenized in lysis buffer 
with a rotor fixed tissue shredder for 30 seconds. 
3. Sample was added to Qiagen spin columns and DNA was digested using the 
Qiagen DNase digest to remove any contaminating genomic DNA following the 
manufacturers. 
4. Inhibitors were washed off the columns using buffers AW1 and AW2 
5. Sample was eluted using 50μl of TE 
Reverse Transcription 
 
1. Reverse transcription reaction was performed using Applied Biosystems high 
capacity cDNA reverse transcription kit and following the manufacturers 
instructions. 
2. Each sample was diluted to 33.75ng/μl and 10μl of each sample was added to a 96 
well plate 
3. 10μl of RT master mix was added to each sample which contained, the reverse 
transcription enzyme, dNTPs, random primers, and H20 at a 1X concentration 
4. The reaction was run using Applied Biosystems Veriti thermal cycler using the 
manufacturers recommendations. 
5. The cDNA was diluted down to 30/8 ng/μl for qPCR 
qPCR 
 
1. The qPCR master mix was created using 10μl/rxn TaqMan Fast Advanced qPCR 
supermix, 1μl/rxn TaqMan primer and probe (FAM), and 1μl/rxn TaqMan 
GAPDH endogenous control (VIC).  
2. 12μl was pipetted into each well of a 96 well plate 
3. 8μl of cDNA sample at 30/8 μl was pipetted into the corresponding well 
4. The reaction was run using the FAST Applied Biosystems protocol on Step One 
Plus qPCR machine, Applied Biosystems 
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qPCR  
For quantification of bacterial copy numbers 
DNA purification 
1. Feces were gently scraped from the intestine tissue one and three days after burn, 
weighed, and gDNA was purified using Qiagen DNA Stool mini kit with the 
procedures for optimizing prokaryotic to eukaryotic DNA.  
2. Feces were lysed in ASL lysis buffer, sonicated for 1min, and placed in a 95°C 
water bath to lyse Gram-positive bacteria. 
3. Proteinase K digestion was performed with the manufacturers instructions to 
digest histone proteins.  
4. DNA was precipitated with 100% ETOH and placed on spin columns 
5. Proteins and other inhibitors were washed using buffer AW1 and AW2 
6. DNA was eluted in 200μl of buffer TE.  
Bacterial Standards 
 
1. Purified bacterial gDNA or cloned bacterial plasmid DNA were used as standards. 
Using 25ng of genomic bacterial DNA with approx. 6 Mbp and .1ng of plasmids 
with approx. 2500 bp gives 10
6
 or 10
7
 copies per standard respectively using the 
formula: Copies =(g DNA)(6.022E10
22
copies/mol)/(bp)(650g/mol/bp) 
2. 10 fold dilutions of standards were made for qPCR 
qPCR 
 
1. Master mix was prepared using SYBR Green Universal qPCR reaction mix (Bio-
Rad). 12μl/rxn of SYBR Green supermix, 2μl/rxn of forward primer (3μM), 
2μl/rxn of reverse primer (3μM). (Table 1 gives primer sequences) 
2. 14μl of master mix were pipetted into a 96 well plate  
3. 6μl of purified gDNA from feces, bacterial standard, or H20 were pipetted into the 
corresponding well 
4. The reaction was run at 95°C for 3 min and 40 cycles of 95°C for 15 sec and the 
corresponding annealing temperature for the primers (Table 1) for 60 sec. on a 
Step One Plus Real Time PCR Machine 
5. Bacterial copy numbers are calculated relative to the standard curve.  
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FISH 
Supplies 
 5M NaCl 
 1M Tris-HCL PH, 7.5 
 10% SDS 
 Pap Pen 
 Hybridization Container 
 Fluorescent probes 
 Xylene 
 100% Ethanol 
 50°C Oven 
 Prolong Gold Antifade with Dapi (Molecular probes) 
Procedures  
 
1. Deparaffinize slides by running them through 4X 3min incubations in Xylene and 
4X 3min incubations in ethanol 
2. Heat the slides at 50°C for approx. 20 min to dry the slides 
3. Prepare hybridization/wash buffer (.9M NaCl, 20mMTris-HCL, pH 7.5, .1% 
SDS), and hybridization container 
4. Mark area of hybridization with Pap pen 
5. Place 500μl of probe diluted to 1ng/ul in hybridization buffer on tissue section 
6. Incubate for 16 hours overnight in dark oven at 50°C 
7. Wash slides in pre-warmed washing buffer (.9M NaCl, 20mMTris-HCL, pH 7.5, 
.1% SDS) for 3X 15minute incubations. 
8. Dry the slides 
9. Counterstain and mount with Prolong Gold Antifade with Dapi 
10. Image using Zeiss 500m fluorescent microscope with AxioVision software 
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ELISA 
 
Tissue Homogenization: 
 
Supplies: 
 
 Lysis buffer, Cell Signaling Technologies 
 Protease Inhibitor Cocktail 
 PMSF 
 Homogenizer Qiagen 
 Sonicator 
Procedure: 
 
1. Prepare lysis buffer: Cell signaling technologies, protease inhibitor cocktail, and 
PMSF to manufacturers instructions 
2. Add 700μl lysis buffer per sample (5cm small intestine tissue or entire large 
intestine tissue from cecum) 
3. Homogenize for 30 seconds with a rotor fixed homogenizer 
4. Sonicate for 10 seconds using a sonicator at setting 3.5 
5. Centrifuge for 30min at 12,000 rpm at 4°C 
6. Remove supernatant and aliquot 
ELISA  
 
Supplies: 
 IL-6 ELISA kit (BD) 
 KC ELISA kit (R&D) 
 Cell Death ELISA kit (Roche) 
Procedure: 
 
1. Samples were diluted depending on the specific ELISA kit used so that the 
unknowns were within the standard curve 
2. ELISA procedure was performed exactly as according to the manufacturers 
protocol, and suggested antibody dilutions 
3. Read plate with a spectrophotometer at 450nm 
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FITC-dextran Permeability Assay 
 
1. On the day of sacrifice, gavage mice.4ml of 22mg/ml FITC-dextran (Sigma-
Aldrich) in PBS.  
2. After 3 hours draw blood and sacrifice the mice.  
3. The blood was centrifuged for 8000rpm for 5min at 4°C, plasma isolated. 
4. Standards of FITC-dextran was prepared using 10 fold dilutions of pure FITC-
dextran in PBS, the high standard being 1mg/ml 
5. Equal volumes of plasma and standard were pipetted into the corresponding well, 
96 well plate 
6. The plate was read spectrophotometrically at 480nm excitation and 520nm 
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